Literature DB >> 1462099

Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors.

E M Messing1.   

Abstract

Growth factors (GFs) are a class of proteins that bind to specific cell surface receptors (GF-Rs), inducing a variety of responses including mitosis, in susceptible target cells. Abnormal production, expression, and/or function of GFs or GF-Rs can result in unregulated growth, the hallmark of malignant transformation. This chapter reviews those GFs/GF-Rs that have been linked to human bladder cancer. It focuses particularly on one [epidermal growth factor (EGF), which is excreted in urine in high concentrations] and its possible role in the development and growth of urothelial malignancy. Potential clinical applications in diagnosis, staging, prevention, and treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462099     DOI: 10.1002/ssu.2980080507

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  6 in total

Review 1.  Sleeping beauty: awakening urothelium from its slumber.

Authors:  Zarine R Balsara; Xue Li
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-25

2.  Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

Authors:  M Inui; N Nishi; A Yasumoto; I Takenaka; H Miyanaka; K Matsumoto; T Nakamura; F Wada
Journal:  Urol Res       Date:  1996

3.  Temporally and spatially controllable gene expression and knockout in mouse urothelium.

Authors:  Haiping Zhou; Yan Liu; Feng He; Lan Mo; Tung-Tien Sun; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-28

4.  Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.

Authors:  Feng He; Lan Mo; Xiao-Yong Zheng; Changkun Hu; Herbert Lepor; Eva Y-H P Lee; Tung-Tien Sun; Xue-Ru Wu
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 5.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

6.  Targeted therapies in the management of metastatic bladder cancer.

Authors:  Matteo Fassan; Edouard J Trabulsi; Leonard G Gomella; Raffaele Baffa
Journal:  Biologics       Date:  2007-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.